Pharma stocks showed strength on Thursday, defying market weakness. Dr Reddy’s Laboratories saw significant gains, fueled by anticipation of approval for its Semaglutide diabetes drug in Canada. Other pharma companies also experienced upward movement. This defensive sector appeal is attracting investors amid uncertain market conditions and geopolitical concerns.
Nasdaq rises 1%, Dow, S&P close higher as weak jobs data tempers rate hike bets
U.S. stocks finished higher following a weaker-than-expected jobs report which eased rate hike expectations. Nonfarm payrolls rose by only 29,000, significantly below economists’ forecasts of